About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
T
PD-1 Inhibitors for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
By
Todd Schlesinger
3 Videos
0 views
May 3, 2023
Comments
0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY
ON
Related
Newest
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
09:00
AAD 2024 Insights
AAD 2024 Insights: What's New In Nail Tumors
Feat.
J. Dominguez-Cherit
11:53
AAD 2024 Insights
AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer
Feat.
V. Patel
21:55
AAD 2024 Insights
AAD 2024 Insights: Management of Locally Advanced Basal Cell Carcino…
Feat.
V. Patel
26:24
EADV 2023 Insights
EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…
Feat.
G. Hofbauer
13:21
NYU Langone
Management of High Risk Squamous Cell Carcinoma
Feat.
M. L. Stevenson
21:20
Dana-Farber Cancer Institute
Year in Review: Updates in Non-Melanoma Skin Cancers
Feat.
K. Khaddour
22:37
Brian Berman
Basal Cell Carcinoma: Pathophysiology of the Hedgehog Pathway and In…
05:58
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV …
Feat.
N. Gross
58:44
Head and Neck Symposium: Skin Malignancies Update
Updates in non-Melanoma Skin Cancer
Feat.
S. Daveluy
47:34
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Head & Neck Cancer Updates
Feat.
C. Rodriguez
27:29
Total Health
2023 ASCO® Direct Philadelphia: Melanoma Updates
Feat.
M. Orloff
15:39
ImmunoTherapy Bridge 2023
Neoadjuvant IO: Non-Melanoma Skin Cancer
Feat.
N. Gross
15:54
ImmunoTherapy Bridge 2023
Non-Melanoma Skin Cancers
Feat.
P. A. Ascierto
24:20
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "To Treat or Not to Treat - Challenging Sc…
Feat.
K. Margolin
02:41
ecancer
ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplima…
Feat.
N. Gross
18:56
Yale Cancer Center
Immunotherapy and Anti-Angiogenic Therapies in HNSCC
Feat.
A. Bhatia
12:13
AACR 2023 Conference Coverage
Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…
Feat.
E. Cohen
09:00
Winship Cancer Institute - Emory University
Harnessing IO in the Management of CSCC
Feat.
N. Saba
25:33
Houston Methodist Hospital
Update on HPV Testing in Head and Neck Cancer
Feat.
M. R. Schwartz
